News & stories

News | Sep 20, 2023

UN pandemic preparedness declaration doesn't do enough

Leaders have a responsibility to ensure health emergency responses take affected people’s needs into consideration.

Story | Jul 13, 2023

Johnson & Johnson deal falls short for people with TB

Johnson & Johnson must end its patent monopoly on bedaquiline so generic versions of this lifesaving drug can be widely produced.

Story | May 16, 2023

Mexico: Stories of adversity and hope from the border

Asylum seekers in Mexico share their experiences searching for safety in the US. 

News | May 16, 2023

MSF responds to NIH director nomination

The new director should adopt policies and practices that ensure equitable access to lifesaving medical products.

News | May 09, 2023

MSF supports reintroduction of Pharmaceutical Research Transparency Act

The legislation requires that pharmaceutical corporations publicly disclose clinical trial costs.

News | Nov 29, 2022

MSF: ViiV must make groundbreaking HIV prevention injection affordable and available

Removing barriers that block access to this medicine could help avoid millions of new HIV infections.

News | Sep 15, 2022

MSF: Cepheid’s production delays of critical tuberculosis test will cost lives

News | Aug 19, 2022

Monkeypox should serve as a global health wake-up call about when we act and why

News | Jun 17, 2022

Inability of WTO members to agree on original TRIPS waiver is a devastating failure for people’s health worldwide

News | Jun 15, 2022

Letter signed by more than 220 groups demands WTO trade ministers not accept current TRIPS waiver draft

Draft ministerial decision on intellectual property waiver woefully inadequate.